Oct192023 CDI Launches MyGI Gateway™: A Cutting-Edge Provider Portal for Enhanced Patient Care Read more
Jul122023 Understanding hydrogen and methane breath tests for SIBO and IMO: 6 Frequently Asked Questions Read more
Apr132023 Trace Gases & Breath Testing for Gastrointestinal Disorders: A GI Community Chat Hosted by CDI Read more
Mar172023 Diagnosing and Treating Functional GI Disorders with a Multidisciplinary Team Approach Read more
Jan252023 Carbohydrate Malabsorption Disorders 101: Sucrose and Fructose and Lactose, Oh My! Read more
Nov162022 CDI’s Craig Strasnick Featured in The Root Cause Medicine Podcast with Dr. Carrie Jones Read more
Oct132022 CDI ISO 13485-Certified Breath Tests Utilized In The Study of Normal Levels of Hydrogen Sulfide In Human Subjects Read more
Aug232022 Commonwealth Diagnostics International (CDI) Expands Access to Naturopathic & Integrative Medicine Community Through New Partnership with Rupa Health Read more
Aug112022 Commonwealth Diagnostics International (CDI) Named Among the Top Healthcare Technology Companies of 2022 Read more
May132022 Digestive Disease Week (DDW 2022) Preview: The Biggest Functional GI Community Topics Read more
Apr192022 IBS Awareness Month + World IBS Day: A GI Community Discussion with Dr. Shanti Eswaran Read more
Mar162022 From Point-of-Care to At-Home Breath Testing: A GI Community Fireside Chat with Dr. Ziad Gellad Read more
Nov152021 Highlights and Recording from 2021 Year in Review + 2022 Outlook Functional GI Trends Webinar Read more
Oct262021 My Total Health Partners with the American College of Gastroenterology to Provide Scientific and Clinical Education to Patients Suffering from GI Symptoms Read more
Sep212021 Breath Testing for Gastrointestinal Conditions and the Importance of Proper Preparation Read more
Jul122021 CDI to Sponsor Upcoming SIBO Workshop Series for Dietitians and Healthcare Providers Read more
Jun292021 Commonwealth Diagnostics International, Inc. Cofounders Honored Amongst Peers in Business and Healthcare Read more
May212021 Commonwealth Diagnostics International, Inc. (CDI) announces expanded industry and research partnerships in the United States and abroad Read more
Apr22021 CDI to Join Industry Stakeholders to Increase Public Awareness of Irritable Bowel Syndrome during IBS Awareness Month and World IBS Day Read more
Feb182021 Breath Testing 101: Learn Everything You Need to Know Before you Prescribe a Breath Test to Your Patient Read more
Feb32021 IBSchek® Granted PLA Code from AMA; CDI to Now Accept Insurance, Providing More Patients At-Home Access Read more
Jan282021 Hydrogen and Methane Breath Testing May Play Important Role In Patients Being Considered for Antireflux Surgery Read more
Jan142021 American College of Gastroenterology Issues Clinical Guidelines for IBS Diagnostics & Treatment Read more
Nov182020 CDI Co-Hosts Webinar with Epicured on Trends & Best Practices for Diagnosing & Treating Functional GI Disorders Read more
Sep172020 Intestinal Methane – Breath Testing Results for Extremely High Methane Production Read more
Jul212020 COVID-19, Aerosolization, and the Impact on Diagnostic Plans for Patients Presenting with GI-Related Symptoms Read more
Mar272020 COVID-19 Response: CDI Commits to Continuity of Care for Functional GI Patients During Time of Uncertainty Read more
Dec202019 CDI Announces Participation in the U.S Department of Veterans Affairs Community Care Network Read more
Jan52019 CDI Announces Its Participation in the Blue Cross Blue Shield of Massachusetts Network Read more
May12018 First Clinically Validated Blood Test for Diagnosing Diarrhea-Predominant and Mixed-Type Irritable Bowel Syndrome Read more
Jan302018 CDI Teams up With PGA Golfer Rob Oppenheim to Drive Awareness of Irritable Bowel Syndrome (IBS) and Small Intestinal Bacterial Overgrowth (SIBO) Read more
May92017 Commonwealth Diagnostics Presents Evidence to Support Improved Testing Methods to Facilitate Diagnosis of Irritable Bowel Syndrome Read more
